首页> 外国专利> Mitochondria: therapeutic compounds based on mitochondria, targeting pathogenic cells, bacteria and yeast

Mitochondria: therapeutic compounds based on mitochondria, targeting pathogenic cells, bacteria and yeast

机译:线粒体:基于线粒体的治疗性化合物,靶向病原细胞,细菌和酵母

摘要

This note refers to mitochondrial function inhibitors. Methods for the detection of compounds used for mitochondrial inhibition have been published. This report also describes the use of methods known as mitochondrial inhibitors, which are therapeutic compounds based on mitochondria with anticancer and antibiotic properties, for the prevention or treatment of cancer, bacterial infection and pathogenic yeast, as well as the use of mitochondrial inhibitors. To provide benefits against aging Some nematode compounds and groups were also reported.
机译:本说明涉及线粒体功能抑制剂。已经公开了检测用于线粒体抑制的化合物的方法。该报告还描述了称为线粒体抑制剂的方法的使用,该方法是基于线粒体的具有抗癌和抗生素特性的治疗性化合物,用于预防或治疗癌症,细菌感染和致病性酵母,以及线粒体抑制剂的使用。为了提供抗衰老的功效,还报道了一些线虫化合物和基团。

著录项

  • 公开/公告号CO2019010027A2

    专利类型

  • 公开/公告日2019-09-30

    原文格式PDF

  • 申请/专利权人 LUNELLA BIOTECH INC.;

    申请/专利号CO20190010027

  • 发明设计人 LISANTI MICHAEL P.;SOTGIA FEDERICA;

    申请日2019-09-16

  • 分类号C07C235/46;C07C275/24;

  • 国家 CO

  • 入库时间 2022-08-21 12:02:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号